Navigation Links
Zimmer Reports Fourth Quarter and 2007 Financial Results
Date:1/29/2008

15 %

Cost of products sold 253.9 207.5 22

Gross Profit 819.6 726.1 13

Research and development 50.8 45.6 11

Selling, general and administrative 401.2 345.6 16

Acquisition, integration and other

expense 15.7 (3.4) 576

Operating expenses 467.7 387.8 21

Operating Profit 351.9 338.3 4

Interest income, net 1.1 1.5 (31)

Earnings before income taxes and

minority interest 353.0 339.8 4

Provision for income taxes 89.0 95.0 (6)

Minority interest (0.2) (0.1) (104)

Net Earnings $263.8 $244.7 8

Earnings Per Common Share

Basic $1.13 $1.03 10

Diluted $1.12 $1.02 10

Weighted Average Common Shares

Outstanding

Basic 233.3 238.5

Diluted 234.8 241.0

ZIMMER HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF EARNINGS

FOR THE TWELVE MONTHS ENDED DECEMBER 31, 2007 and 2006

(in millions, except per share amounts)

2007 2006 % Inc/(Dec)

(unaudited)

Net Sales $3,897.5 $3,495.4 12 %

Cost of products sold 875.9 780.1 12

Gross Profit 3,021.6
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
2. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
3. Zimmer Holdings to Present at JPMorgan Healthcare Conference
4. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings to Present at Upcoming Investor Conferences
7. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
9. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
10. Amylin Pharmaceuticals Reports 2007 Financial Results
11. Cystic Fibrosis Foundation reports upward trend for key health outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An online ... decision to make the purchase of CPAP equipment more affordable by offering shipping at ... all types of CPAP products and orders of any size. My Cpap Store is ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An ... that local pizza maker Paul LaRocco has gone through to open a pizzeria in ... and permitting process tends to take several months, but the current process, having already ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... FDA’s Position and Best Practices for Compliance, **Presented by FDAnews and GessNet**, ... chaired by internationally renowned expert Fubin Wu, has been specifically designed to ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, ... the “Music With A Mission” benefit concert in Mendon, IL. Held in the Show ... money to support music education programs in the underfunded local school districts of Mendon ...
Breaking Medicine News(10 mins):Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Article on Building Approval Process for LA Business Highlights the Need for a Bridge Between Businesses and City Officials, says Fire Protection Group Inc. 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... on the Vine Varieties not Subject to Salmonella ... ... brand, and is North America,s largest grower of greenhouse,tomatoes, wants to let consumers ... US are not subject to the most recent June,7, 2008 Salmonella alert issued ...
... ST. LOUIS, June 9 ETHEX Corporation announced today,that ... sulfate 60 mg,extended release tablets (Lot No. 91762) due ... thickness. Oversized tablets may contain as much as,two times ... was,distributed by ETHEX Corporation under an "ETHEX" label between ...
... parasite, a team of researchers has been able to ... has thereby broken the cycle of infection during recent ... parasite through gene knock-out technol-ogy, a research team consisting ... Hopkins University, Baltimore, has prevented the parasite from going ...
... both genders over 25-year period , , MONDAY, June 9 ... arteries work just as well in women as in men, ... recent years, new research finds. , The study in the ... College of Cardiology is a marker in a fading ...
... Sen. Max Baucus,(D-MT), chair of the Senate ... bill that includes pharmacy-related provisions to provide ... claims and delay the,implementation of Medicaid reimbursement ... Roberts, RPh, executive vice president and CEO ...
... ALBANY, Ore., June 9 Synthetech, Inc. (OTC,Bulletin ... 2008 Dr. Gregory R.,Hahn will become Synthetech,s President ... has served as Synthetech,s President and Chief,Operating Officer. ... Dr.,Daniel T. Fagan, who will continue as Synthetech,s ...
Cached Medicine News:Health News:Consumers Can Purchase Majority of Tomato Varieties 2Health News:ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets 2Health News:ETHEX Corporation Voluntarily Recalls a Single Lot of Morphine Sulfate 60 mg Extended Release Tablets Due to the Potential for Oversized Tablets 3Health News:Researchers block transmission of malaria in animal tests 2Health News:Researchers block transmission of malaria in animal tests 3Health News:Artery-Opening Method Works Well in Women 2Health News:Artery-Opening Method Works Well in Women 3Health News:NCPA Statement on Sen. Baucus' Medicare Bill Inclusion of Solutions for Medicare and Medicaid Reimbursement Problems 2Health News:Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer 2Health News:Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer 3
(Date:8/28/2015)... , Aug. 28, 2015 , ... Dr. Ra from Biostar , Published in ,Stem ... increase of lifespan through multiple IV administration of Adipose-derived ... and life expectancy found , Commercialization within 5 ... determined the possibility that adult mesenchymal stem cells (MSCs) ...
(Date:8/28/2015)... and LONDON , August 28, 2015 ... approach seamlessly connects people, technologies ... improving outcomes and the cost of ... PHG AEX: PHIA) today announced its presence at  ESC Congress ... solutions, including Heart Model A.I. , EchoNavigator and IntelliSpace Cardiovascular, ...
(Date:8/27/2015)... 27, 2015  A recent study by Feucht ... compared the Arthrosurface HemiCAP® Wave implant, which is ... "onlay" design implant for isolated patellofemoral disease. While ... and pain scores, none of the patients in ... However, 53% of the patients in the "onlay" ...
Breaking Medicine Technology:Korean Researchers Find the Possibility that Adult Mesenchymal Stem Cells (MSCs) May Extend Lifespan 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3
... pressure intravascular catheters provide a simple, ... measuring pressures in the heart or ... catheters are ideal for high fidelity ... size from 2 to 7 French ...
... Mikro-Tip pressure intravascular catheters provide a ... of measuring pressures in the heart ... Mikro-Tip catheters are ideal for high ... in size from 2 to 7 ...
... dual pressure sensor catheters incorporate ... slow-speed injection/guide wire, or high-speed ... for high-speed injection has two ... and an open-end pigtail extension ...
... dBC is a flat detector biplane ... ideal for cardiological diagnostics and intervention. ... you to optimally adapt the system ... and electrophysiological applications with tableside operation. ...
Medicine Products: